Document Detail

Serum sialic acid and ankle versus brachial arterial-pressure ratio in NIDDM.
MedLine Citation:
PMID:  9819193     Owner:  NLM     Status:  MEDLINE    
Serum sialic acid is related to mortality from cardiovascular disease and is increased in patients with diabetic microangiopathies. The purpose of this study was to examine whether serum sialic acid is associated with ischemic disease of the lower extremities, using the ankle versus brachial arterial-pressure ratio. The subjects were NIDDM patients attending diabetic clinics. They received a questionnaire on smoking and duration of diabetes, and physical examinations including measurement of blood pressure of upper and lower extremities. Fasting blood was taken for measurement of sialic acid, total and HDL cholesterol, and HbA1c. Serum sialic acid was significantly correlated with ankle versus brachial arterial-pressure ratio (r = -0.32) and HbA1c (r=0.45). The correlation with ankle versus brachial arterial-pressure ratio was evident in the patients with low ankle versus brachial arterial-pressure ratios (r = -0.66), but was not significant in those with normal ankle versus brachial arterial-pressure ratios (r=0.16). The correlation with HbA1c was significant independently of ankle versus brachial arterial-pressure ratios. Mean serum sialic acid was higher in patients with very low ankle versus brachial arterial-pressure ratios (< 0.9) than in those with normal ankle versus brachial arterial-pressure ratios (> or = 1.0) or slightly low ankle versus brachial arterial-pressure ratios (0.9 approximately 1.0). These results suggest that serum sialic acid reflects the status of blood glucose control and the progression of ischemic disease of the lower extremities in NIDDM patients.
H Masuda; R Wakabayashi; I Wakabayashi
Related Documents :
2936853 - The haemodynamic effects of percutaneous transluminal angioplasty.
4007993 - Lack of alerting reactions to intermittent cuff inflations during noninvasive blood pre...
2984913 - A parallel study of enalapril and captopril and 1 year of experience with enalapril tre...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  Scandinavian journal of clinical and laboratory investigation     Volume:  58     ISSN:  0036-5513     ISO Abbreviation:  Scand. J. Clin. Lab. Invest.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1999-01-07     Completed Date:  1999-01-07     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0404375     Medline TA:  Scand J Clin Lab Invest     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  433-39     Citation Subset:  IM    
Second Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Blood Pressure Determination / methods*
Brachial Artery
Cholesterol / blood
Diabetes Mellitus, Type 2 / blood,  complications,  physiopathology*
Hemoglobin A, Glycosylated / analysis
Ischemia / blood,  complications,  physiopathology
Leg / blood supply
N-Acetylneuraminic Acid / blood*
Reg. No./Substance:
0/Hemoglobin A, Glycosylated; 131-48-6/N-Acetylneuraminic Acid; 57-88-5/Cholesterol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis.
Next Document:  An O-glycosylated neuroexcitatory conus peptide.